147 related articles for article (PubMed ID: 15217296)
1. A new dimension to the biosynthetic products isolated from the sponge Negombata magnifica.
Vilozny B; Amagata T; Mooberry SL; Crews P
J Nat Prod; 2004 Jun; 67(6):1055-7. PubMed ID: 15217296
[TBL] [Abstract][Full Text] [Related]
2. Bioactive natural and semisynthetic latrunculins.
El Sayed KA; Youssef DT; Marchetti D
J Nat Prod; 2006 Feb; 69(2):219-23. PubMed ID: 16499319
[TBL] [Abstract][Full Text] [Related]
3. Toward computing relative configurations: 16-epi-latrunculin B, a new stereoisomer of the actin polymerization inhibitor latrunculin B.
Hoye TR; Ayyad SE; Eklov BM; Hashish NE; Shier WT; El-Sayed KA; Hamann MT
J Am Chem Soc; 2002 Jun; 124(25):7405-10. PubMed ID: 12071749
[TBL] [Abstract][Full Text] [Related]
4. Quantitative determination of latrunculins A and B in the Red Sea sponge Negombata magnifica by high performance liquid chromatography.
Khalifa S; Ahmed S; Mesbah M; Youssef D; Hamann M
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 832(1):47-51. PubMed ID: 16431167
[TBL] [Abstract][Full Text] [Related]
5. Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity.
Kudrimoti S; Ahmed SA; Daga PR; Wahba AE; Khalifa SI; Doerksen RJ; Hamann MT
Bioorg Med Chem; 2009 Nov; 17(21):7517-22. PubMed ID: 19800245
[TBL] [Abstract][Full Text] [Related]
6. Molecular and protein characterization of two species of the latrunculin-producing sponge Negombata from the Red Sea.
Eid ES; Abo-Elmatty DM; Hanora A; Mesbah NM; Abou-El-Ela SH
J Pharm Biomed Anal; 2011 Dec; 56(5):911-5. PubMed ID: 21852057
[TBL] [Abstract][Full Text] [Related]
7. Interrogating the bioactive pharmacophore of the latrunculin chemotype by investigating the metabolites of two taxonomically unrelated sponges.
Amagata T; Johnson TA; Cichewicz RH; Tenney K; Mooberry SL; Media J; Edelstein M; Valeriote FA; Crews P
J Med Chem; 2008 Nov; 51(22):7234-42. PubMed ID: 18942825
[TBL] [Abstract][Full Text] [Related]
8. Latrunculins--novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D.
Spector I; Shochet NR; Blasberger D; Kashman Y
Cell Motil Cytoskeleton; 1989; 13(3):127-44. PubMed ID: 2776221
[TBL] [Abstract][Full Text] [Related]
9. A reassignment of (-)-mycothiazole and the isolation of a related diol.
Sonnenschein RN; Johnson TA; Tenney K; Valeriote FA; Crews P
J Nat Prod; 2006 Jan; 69(1):145-7. PubMed ID: 16441088
[TBL] [Abstract][Full Text] [Related]
10. Microfilament-disrupting agent latrunculin A induces and increased number of fenestrae in rat liver sinusoidal endothelial cells: comparison with cytochalasin B.
Braet F; De Zanger R; Jans D; Spector I; Wisse E
Hepatology; 1996 Sep; 24(3):627-35. PubMed ID: 8781335
[TBL] [Abstract][Full Text] [Related]
11. Magnificines A and B, Antimicrobial Marine Alkaloids Featuring a Tetrahydrooxazolo[3,2-a]azepine-2,5(
Youssef DTA; Asfour HZ; Genta-Jouve G; Shaala LA
Mar Drugs; 2021 Apr; 19(4):. PubMed ID: 33921326
[TBL] [Abstract][Full Text] [Related]
12. Latrunculin alters the actin-monomer subunit interface to prevent polymerization.
Morton WM; Ayscough KR; McLaughlin PJ
Nat Cell Biol; 2000 Jun; 2(6):376-8. PubMed ID: 10854330
[No Abstract] [Full Text] [Related]
13. Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking.
Ahmed SA; Odde S; Daga PR; Bowling JJ; Mesbah MK; Youssef DT; Khalifa SI; Doerksen RJ; Hamann MT
Org Lett; 2007 Nov; 9(23):4773-6. PubMed ID: 17929935
[TBL] [Abstract][Full Text] [Related]
14. Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.
Sayed KA; Khanfar MA; Shallal HM; Muralidharan A; Awate B; Youssef DT; Liu Y; Zhou YD; Nagle DG; Shah G
J Nat Prod; 2008 Mar; 71(3):396-402. PubMed ID: 18298079
[TBL] [Abstract][Full Text] [Related]
15. Monanchorin, a bicyclic alkaloid from the sponge Monanchora ungiculata.
Meragelman KM; McKee TC; McMahon JB
J Nat Prod; 2004 Jul; 67(7):1165-7. PubMed ID: 15270573
[TBL] [Abstract][Full Text] [Related]
16. Differential binding of latrunculins to G-actin: a molecular dynamics study.
Helal MA; Khalifa S; Ahmed S
J Chem Inf Model; 2013 Sep; 53(9):2369-75. PubMed ID: 23988111
[TBL] [Abstract][Full Text] [Related]
17. Latrunculin A is a potent inducer of aggregation of polymorphonuclear leukocytes.
Oliveira CA; Chedraoui S; Mantovani B
Life Sci; 1997; 61(6):603-9. PubMed ID: 9250716
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of actin polymerization by latrunculin A.
Coué M; Brenner SL; Spector I; Korn ED
FEBS Lett; 1987 Mar; 213(2):316-8. PubMed ID: 3556584
[TBL] [Abstract][Full Text] [Related]
19. Effect of latrunculin-B on outflow facility in monkeys.
Peterson JA; Tian B; Geiger B; Kaufman PL
Exp Eye Res; 2000 Mar; 70(3):307-13. PubMed ID: 10712817
[TBL] [Abstract][Full Text] [Related]
20. Latrunculin A is a potent inhibitor of phagocytosis by macrophages.
de Oliveira CA; Mantovani B
Life Sci; 1988; 43(22):1825-30. PubMed ID: 3200109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
